15 Rue Traversiere
Paris 75012
France
33 1 89 20 62 00
https://www.euroapi.com/en
Settore/i:
Settore:
Impiegati a tempo pieno: 3.329
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Ludwig De Mot | CEO, Executive VP & Chief Transformation Officer | N/D | N/D | 1963 |
Mr. Antoine Delcour | Chief Financial Officer | N/D | N/D | N/D |
Mr. David Seignolle | Chief Operating Officer | N/D | N/D | N/D |
Mr. Kai Rossen | Chief Scientific Officer | N/D | N/D | N/D |
Sophie Palliez | Head of Investor Relations | N/D | N/D | N/D |
Ms. Marion Santin | Chief Legal, Compliance, & IP Officer | N/D | N/D | N/D |
Ute Herzog | Chief Human Resources Officer | N/D | N/D | N/D |
Ms. Cecile Maupas | Chief CDMO (Contract Development and Manufacturing Organization) Officer | N/D | N/D | N/D |
Mr. Vincent Touraille | Chief Strategy and M&A Officer | N/D | N/D | 1963 |
Mr. Bruno Laforge | Chief Corporate Affairs Officer | N/D | N/D | N/D |
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. It provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids. The company was incorporated in 2020 and is based in Paris, France.
L'ISS Governance QualityScore di Euroapi S.A. al 1 maggio 2024 è 3. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 3; diritti degli azionisti: 1; retribuzione: 5.